Full text is available at the source.
Abstract
Fatigue affects 50% to 90% of patients with multiple sclerosis, Parkinson's disease, stroke, ME/CFS, and long COVID.
- Fatigue is recognized as a significant barrier to rehabilitation participation in these patient populations.
- The underlying mechanisms of fatigue in these conditions remain poorly understood.
- Despite extensive research over decades, effective strategies for managing fatigue have not been established.
Simplified